Extrahepatic complications of nonalcoholic fatty liver disease.
about
Osteoporosis in liver disease: pathogenesis and managementInsulin resistance in development and progression of nonalcoholic fatty liver diseaseTreatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightGlycosyltransferases and non-alcoholic fatty liver diseaseTreating morbid obesity in cirrhosis: A quest of holy grailComorbidities and Metabolic Derangement of NAFLDCardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An updateSpaceflight Activates Lipotoxic Pathways in Mouse LiverNonalcoholic fatty liver disease and vascular disease: state-of-the-art.The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseNonalcoholic fatty liver disease - A multisystem disease?Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III StudyDevelopmental origins of NAFLD: a womb with a clue.Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram.Non-Alcoholic Fatty Liver Disease Association with Cardiac ArrhythmiasRelationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity.Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesNutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.USF-1 genetic polymorphisms confer a high risk of nonalcoholic fatty liver disease in Chinese population.Practical approach to non-alcoholic fatty liver disease in patients with diabetes.S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability.Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 DiabetesReplacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined OilSerum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study.Mechanism of Altered Metformin Distribution in Nonalcoholic SteatohepatitisAssociations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluationEpicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicityGlucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseAGTR1 rs3772622 gene polymorphism increase the risk of nonalcoholic fatty liver disease patients suffer coronary artery disease in Northern Chinese Han population
P2860
Q26746935-E83D98E2-A727-44B2-BA2F-5916DB51FAF4Q26748687-9BA4DB88-7486-4975-AEE1-0B7F99682733Q26751258-BDAF24C2-9B81-42DC-BEA3-C9752E0F37F8Q26752583-99E57308-A1E9-4244-84E5-8075BC160297Q26764913-AB3873E4-02D8-46AE-AC1D-B1E0425AA52AQ26775811-5FB075BA-492D-43DD-9633-662B6FF3C69BQ26777147-FF10618B-5E11-4E3D-9DAD-BFB02BE7E3EDQ26997059-672143FD-DC74-4C54-8463-1FFC40423876Q27315146-664D1061-DCD9-40C4-B106-1EB1855A7BB8Q27692035-966A35CD-48A4-4D4D-898E-B9BD1984DDB4Q28078754-74B6BA3D-B302-4E37-8E87-043FEB7AD2A8Q28079077-7CC1F6A6-C37F-4882-8144-58DACFC0AF4CQ28391820-6C30E9FF-EEFD-4281-A9D0-99F44FD37905Q30241940-592EA0CF-56DB-4DEB-B689-4E6E9E8CE51BQ30377409-B32F9FAB-E1A6-4BF1-A909-1F2B79BFFA13Q33591227-81048D63-DFC8-4B05-8760-24A35632F5D1Q33675914-B55D18AE-FA6C-43AE-ADDB-7ABFC03DB822Q33823038-EA47366A-DB0D-42C0-BA7C-0665A1BECE72Q33886948-670065B0-8B7C-405D-91FA-B2F0DB589A36Q34728267-A9F32E82-F8D3-47FC-B9EC-C20B005B2BCFQ35074953-1D680427-49A7-4C0C-84FA-43E87487C681Q35108120-CDA5AAD7-0B9C-40EB-9D6E-6AC620EFD716Q35188136-8CBCCAEB-C28F-47DB-8198-2A136BF71961Q35480721-BE21363D-F798-4283-BC9D-533A6E43B5A7Q35561693-2BCB1E53-F5C5-4848-8212-9C61333E9AE2Q35624711-5B882216-2D2A-4713-9113-1D75DBC5FD6FQ35689076-F7E09614-7D25-415F-BB4F-D87CEE0A1E7EQ35704998-9B89D156-FECF-4B22-A077-61DD47CA8DB6Q35740071-7ECC6378-5A92-4818-8326-804462202FB2Q35787531-6161C99D-039A-4091-809E-ACB607FEDD85Q35797825-7383AA36-A67C-40AC-971D-214542B694EBQ35973910-E212D7FB-2C7E-4AF7-8ABD-EB4B8E22C224Q36003451-C8122F40-9EF3-4110-902D-4077BCBF0A30Q36062584-BAAC17BB-86E8-4CA0-BAF3-EDC5FC6601FEQ36132807-6194B8A3-A843-4ABA-A6AA-9CB025CFCE3FQ36231960-3FDCF9E5-8DD5-44D5-A594-9846AA5E6E48Q36363349-2399BB7B-9A98-4748-BF1E-461C1440036FQ36465496-1C4B900A-5AF8-4519-8225-8CC651318E60Q36921610-30C6190C-5E8B-4866-9CF1-C317F26B2643Q37035390-4D1E77C7-5F0C-4539-8443-5054D3EA4DA9
P2860
Extrahepatic complications of nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Extrahepatic complications of nonalcoholic fatty liver disease.
@en
type
label
Extrahepatic complications of nonalcoholic fatty liver disease.
@en
prefLabel
Extrahepatic complications of nonalcoholic fatty liver disease.
@en
P356
P1433
P1476
Extrahepatic complications of nonalcoholic fatty liver disease.
@en
P2093
Leon A Adams
Wing-Kin Syn
P304
P356
10.1002/HEP.26717
P407
P577
2014-01-16T00:00:00Z